换一批
换一批Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA.
第一作者：
Peggy L,Lin
第一单位：
a 1 Analysis Group, Inc. , 111 Huntington Ave, 10th Floor, Boston, MA 02199, USA +1 617 425 8475 ; +1 617 425 8001 ; peggy.lin@analysisgroup.com.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肝肿瘤(Liver Neoplasms);中年人(Middle Aged);比例危险度模型(Proportional Hazards Models);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone)
DOI
10.1517/14656566.2015.1074182
PMID
26290278
发布时间
2018-12-02
- 浏览52
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
